corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 2379

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: media release

Impactrx .
ImpactRx Announces the Launch of SampleLink™
ImpactRx 2005 Aug 24
http://www.impactrx.com/presscenter/releases/2005-0825.asp?on=headlines

Keywords:
SampleLink behaviour samples


Notes:

Ralph Faggotter’s Comments: Any doctor who is naiive enough to think that the handing over of free samples is a casual act of courtesy, should read this press release from a company which can carefully monitor their response to this seemingly insignificant gesture.
You may not know it, but that little box of sample pills can dramatically influence your prescribing patterns!


Full text:

ImpactRx Announces the Launch of SampleLinkâ„¢

~ New Jersey-Based Pharmaceutical Data Provider Launches First of Its Kind Product ~

Mount Laurel, N.J., August 24, 2005 – ImpactRx, Inc., innovative provider of quantitative insight on key influencers of physician behavior to the pharmaceutical industry, today announced the launch of SampleLinkâ„¢, a new tool specifically designed to provide actionable insights on prescription drug sampling.

Pharmaceutical promotional investment in product samples is second only to sales force costs, with retail value exceeding $10 billion annually. Yet, limited data are available to guide decisions on sample expenditures and deployment without embarking on extensive and lengthy analytical projects.

SampleLinkâ„¢ is designed to help clients develop and measure the impact of product samples at point of treatment. SampleLinkâ„¢ leverages ImpactRx’s unique data acquisition technology and breadth of longitudinal promotion and treatment data, with sample-specific productivity metrics to provide actionable insights into appropriate sample levels and effective sample deployment.

“Pharma’s ability to measure and track effectiveness of samples has been hampered by the almost total lack of sample data and easy to use analytical tools. As managed care and Medicare formularies become tighter, and pharma profitability challenges increase, it will be critical to understand how samples impact brand ROI,” said Nancy Lurker, CEO and President of ImpactRx… “We are extremely pleased to offer SampleLinkâ„¢ to provide insight into sample investment and deployment.”

About ImpactRx
Founded in October 2000, ImpactRx’s physician network is the source of unprecedented intelligence capability for assessing the impact of key pharmaceutical brand drivers on physician behavior and brand performance. Based in Mount Laurel , New Jersey , ImpactRx is a privately held company.

  1. # #

Contact Information:

Fred Nelson
Senior Vice President of Marketing and Public Relations
ImpactRx, Inc.
856-273-0221, ext. 142
fnelson@impactrx.com

Sara Kassabian
MCS Public Relations
(800) 477-9626
SaraK@mcspr.com

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963